Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins (Q38357543)

2 September 2017

title

Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins (English)

1 reference

2 September 2017

Vitetta ES

1 reference

2 September 2017

Ghetie V

1 reference

2 September 2017

Herrera L

1 reference

2 September 2017

Yarbrough S

series ordinal

1 reference

2 September 2017

Aquino DB

series ordinal

1 reference

2 September 2017

language of work or name

1 reference

1 February 2003

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

334-338

1 reference

Chemotherapy of childhood lymphoblastic leukaemia: the first 50 years

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402790

Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402790

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402790

Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402790

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2402790

1 reference

Dimensions Publication ID

2 September 2017

1050725834

0 references

1 reference